Amphenol (APH) Stock News Today: December 17, 2025 Updates, Forecasts, Analyst Targets, and What Investors Are Watching

Amphenol (APH) Stock News Today: December 17, 2025 Updates, Forecasts, Analyst Targets, and What Investors Are Watching

Amphenol Corporation (NYSE: APH) is back in focus on Wednesday, December 17, after a wave of fresh notes and market chatter centered on its AI-linked connectivity exposure, segment momentum, valuation, and insider/institutional activity. Shares were last trading around $126.50, down about 2% on the day at the time of reporting. Below is a comprehensive, publication-ready roundup of the key Amphenol stock news, forecasts, and analyses dated December 17, 2025, along with the numbers shaping the near-term outlook. Amphenol stock price today: APH slips as investors reassess valuation after a blockbuster 2025 After an exceptional run in 2025, APH is seeing
17 December 2025
MercadoLibre Stock (MELI) News, Forecasts and Analysis for Dec. 17, 2025: Insider Sale, Options Whales, and 2026 Catalysts

MercadoLibre Stock (MELI) News, Forecasts and Analysis for Dec. 17, 2025: Insider Sale, Options Whales, and 2026 Catalysts

MercadoLibre, Inc. (NASDAQ: MELI) is back in focus on December 17, 2025, as investors weigh a fresh wave of stock-market signals—from notable insider selling and unusual options activity to institutional ownership updates—against the company’s powerful long-term thesis: dominant Latin American e-commerce paired with fast-growing fintech (Mercado Pago). Shares traded around the low-to-mid $1,900s in Wednesday’s session, with reported intraday levels roughly spanning the $1,900–$1,950 area and a stated 52-week range of $1,646 to $2,645.22. Investing.com Below is a detailed, publication-ready roundup of today’s MercadoLibre stock news, the latest Wall Street forecasts, and the key fundamental story investors are using to
17 December 2025
IES Holdings (IESC) Stock Drops on Dec. 17, 2025: What’s Driving the Move, Latest Earnings, Insider Sales, and Wall Street Forecasts

IES Holdings (IESC) Stock Drops on Dec. 17, 2025: What’s Driving the Move, Latest Earnings, Insider Sales, and Wall Street Forecasts

IES Holdings, Inc. (NASDAQ: IESC) saw a sharp pullback in Wednesday trading on December 17, 2025, after a strong multi-year run that has increasingly tied the company’s narrative to data center demand, capacity expansion, and active capital allocation. As of the latest available trade on Dec. 17, IESC was trading around $405, down roughly 9% from the prior close (after opening above $446 and touching an intraday high near $451). In earlier reporting the same day, MarketBeat described the decline as about 5.6%, with the stock quoted near $422 at that time. MarketBeat So what’s behind the volatility—and what should
Intel Stock (INTC) Today: Key News, Forecasts, and Catalysts to Watch on December 17, 2025

Intel Stock (INTC) Today: Key News, Forecasts, and Catalysts to Watch on December 17, 2025

Intel Corporation (NASDAQ: INTC) is back in the spotlight on Wednesday, December 17, 2025, with the stock pulling back as investors weigh a rare mix of geopolitical risk, foundry technology momentum, and fresh deal speculation. Shares traded around $36–$37 in U.S. session pricing, down roughly 2% at the time of the latest available snapshot, with the day’s range hovering in the mid-to-high $30s. Investors are also trying to square this pullback with the bigger picture: Intel stock has still logged a strong 2025 run, up more than 80% year to date by some real-time trackers. MarketScreener What’s driving the debate
Fluence Energy (FLNC) Stock Today: Why Shares Are Sliding on Dec. 17, 2025 as 2026 Growth Guidance Collides With Bearish Options Flow

Fluence Energy (FLNC) Stock Today: Why Shares Are Sliding on Dec. 17, 2025 as 2026 Growth Guidance Collides With Bearish Options Flow

Fluence Energy, Inc. (NASDAQ: FLNC) is back in the spotlight on Wednesday, December 17, 2025, as the battery energy storage and grid-optimization specialist sees a sharp reversal in trading and renewed debate about what its FY2026 growth outlook is really worth after a volatile December run. As of the latest available quote, FLNC traded at about $19.41, down roughly $1.90 versus the prior close—an approximately 8.9% decline—after swinging between roughly $21.87 and $19.02 on the day. Below is what’s driving the move, what analysts and forecasts are saying now, and which catalysts matter most for Fluence Energy stock heading into
Goldman Sachs (GS) Stock News Today: Analyst Price Targets, Fed Update, and What Could Move Shares Next (Dec. 17, 2025)

Goldman Sachs (GS) Stock News Today: Analyst Price Targets, Fed Update, and What Could Move Shares Next (Dec. 17, 2025)

The Goldman Sachs Group, Inc. (NYSE: GS) is trading modestly lower on Wednesday, December 17, 2025, as a tech-led pullback pressures major U.S. indexes and keeps investors focused on rates, deal activity, and year-end positioning. As of 18:03 UTC, GS shares were at $873.06, down about 0.69% on the day, after trading between $871.91 and $895.68. Even with today’s softness, Goldman remains one of the market’s standout financial winners in 2025: Yahoo Finance’s total return figure shows GS up 58.38% year-to-date as of December 17. Yahoo Finance Below is a full roundup of the key GS stock headlines published on
17 December 2025
Fermi Inc (FRMI) Stock News Today: Why Shares Are Swinging, Latest SEC Filing, and Analyst Price Targets (Dec. 17, 2025)

Fermi Inc (FRMI) Stock News Today: Why Shares Are Swinging, Latest SEC Filing, and Analyst Price Targets (Dec. 17, 2025)

Fermi Inc. (NASDAQ: FRMI; LSE: FRMI) stock is back in the spotlight on Wednesday, December 17, 2025, after another volatile session that followed last week’s sharp selloff and Tuesday’s strong rebound. In early afternoon trading, FRMI was changing hands around $8.85, down about 9% on the day after opening near $10.00 and sliding as low as $8.75, with volume approaching 4.25 million shares. The latest move comes as investors digest a key development disclosed in a recent SEC filing: a prospective “first tenant” for Fermi’s flagship Project Matador in Texas terminated an agreement that could have advanced up to $150
17 December 2025
Bloom Energy (BE) Stock Drops on AI-Power Jitters and Rising Competition: News, Forecasts, and What’s Next (Dec. 17, 2025)

Bloom Energy (BE) Stock Drops on AI-Power Jitters and Rising Competition: News, Forecasts, and What’s Next (Dec. 17, 2025)

Bloom Energy Corporation (NYSE: BE) stock slid sharply on Wednesday, December 17, 2025, as investors reassessed the “AI data center power” trade that helped drive the shares higher for much of the year. BE was trading around $78–$79 late Wednesday, down roughly 10% on the day, after opening near the high-$80s and touching the low-$78s intraday. Investing.com+1 The move is the latest reminder that Bloom—now widely viewed as a proxy for AI-driven electricity demand—can react violently to changes in sentiment around hyperscalers, data center buildouts, and the cost of capital. Below is a full roundup of the latest December 17,
Exxon Mobil (XOM) Stock News Today: Oil Rebounds on Venezuela Blockade Shock, Analyst Targets Hold Near $130 — What Investors Are Watching (Dec. 17, 2025)

Exxon Mobil (XOM) Stock News Today: Oil Rebounds on Venezuela Blockade Shock, Analyst Targets Hold Near $130 — What Investors Are Watching (Dec. 17, 2025)

Exxon Mobil Corporation (NYSE: XOM) is trading higher on Wednesday, December 17, 2025, as a sharp rebound in crude oil prices lifts sentiment across the energy sector. In mid‑day U.S. trading, XOM hovered around $116.5–$116.7, up roughly 1.6%–1.8% on the session, after closing Tuesday at $114.68. StockAnalysis The catalyst is geopolitical: oil prices climbed after President Donald Trump ordered what he called a blockade of sanctioned oil tankers entering and leaving Venezuela, injecting fresh uncertainty into near‑term supply expectations. Reuters Below is a detailed roundup of the key Dec. 17 headlines driving the tape, plus the latest Wall Street forecasts
17 December 2025
Uber Stock News Today (Dec. 17, 2025): UBER Slips as FTC Uber One Lawsuit Expands; Analyst Price Targets and 2026 Outlook

Uber Stock News Today (Dec. 17, 2025): UBER Slips as FTC Uber One Lawsuit Expands; Analyst Price Targets and 2026 Outlook

December 17, 2025 — Uber Technologies, Inc. (NYSE: UBER) stock is under pressure again as investors digest a fresh wave of regulatory headlines tied to Uber’s subscription business, alongside a new analyst price-target adjustment that underscores how sentiment has cooled after a strong 2025 run. As of late trading on Dec. 17, Uber stock was at $80.06, down $0.86 (-1.06%) on the day, with the session ranging from $79.26 to $81.47. While Uber remains one of the most closely watched mobility and delivery names on Wall Street, the market’s near-term focus has shifted sharply toward legal and regulatory risk—especially around
17 December 2025
EverCommerce (EVCM) Stock Falls on Dec. 17, 2025 After a 52-Week High: What Today’s News, Insider Filings, and Analyst Forecasts Say

EverCommerce (EVCM) Stock Falls on Dec. 17, 2025 After a 52-Week High: What Today’s News, Insider Filings, and Analyst Forecasts Say

December 17, 2025 — EverCommerce Inc. (NASDAQ: EVCM) saw sharp volatility in Wednesday trading, pulling back after a powerful short-term run that included a fresh 52-week high just one session earlier. By midday, EVCM was trading around $11.85, down about 11.6% from the prior close, after swinging between roughly $11.72 and $13.42. StockAnalysis That reversal is drawing attention because it follows a rapid climb in early-to-mid December: EVCM closed at $13.40 on Dec. 16 after touching $14.41 intraday—and had risen more than 50% in roughly two weeks (from the Dec. 2 close of $8.88 to the Dec. 16 close of
17 December 2025
Johnson & Johnson Stock (JNJ) News Today: RBC Raises Target to $240 as FDA Actions and Talc Verdict Shape the 2026 Outlook

Johnson & Johnson Stock (JNJ) News Today: RBC Raises Target to $240 as FDA Actions and Talc Verdict Shape the 2026 Outlook

CAs of Wednesday, December 17, 2025, Johnson & Johnson (NYSE: JNJ) is back in focus for investors looking for a “defensive” large-cap healthcare stock—while also weighing two forces that can move JNJ shares quickly: drug pipeline catalysts and talc litigation headlines. JNJ shares are trading around $210 today, after a volatile stretch that included a sharp pullback on Tuesday, December 16, and renewed analyst attention mid-week. StockAnalysis JNJ stock snapshot: where shares stand on December 17, 2025 JNJ is hovering near the low-$210s, a level that puts the stock close to recent highs for 2025—an important context point because it
17 December 2025
Albemarle Stock (NYSE: ALB) Jumps to a Fresh High as Lithium Prices Spike and Analysts Lift Targets (Dec. 17, 2025)

Albemarle Stock (NYSE: ALB) Jumps to a Fresh High as Lithium Prices Spike and Analysts Lift Targets (Dec. 17, 2025)

Albemarle Corporation stock (NYSE: ALB) is back in the spotlight on Wednesday, December 17, 2025, as a renewed rally in lithium prices collides with a wave of updated Wall Street targets. Shares climbed roughly 4%–5% in U.S. trading and touched a fresh 52‑week high around the high‑$130s, according to multiple market data feeds. Investing.com+2MarketScreener+2 Today’s price action isn’t about a single headline. Instead, it reflects a “stack” of catalysts that matter for lithium producers: tightening supply narratives out of China, a clearer demand signal from energy storage, and analysts recalibrating what an earnings recovery could look like if higher lithium
17 December 2025
AppLovin (APP) Stock News Today (Dec. 17, 2025): BTIG Lifts Price Target as Wedbush Highlights Axon Momentum—Latest Forecasts and Key Risks

AppLovin (APP) Stock News Today (Dec. 17, 2025): BTIG Lifts Price Target as Wedbush Highlights Axon Momentum—Latest Forecasts and Key Risks

AppLovin Corporation (NASDAQ: APP) is back on traders’ radars on Wednesday, Dec. 17, 2025, as fresh analyst commentary lands while the stock continues to consolidate near recent highs after a powerful 2025 run. By midday in the U.S. session, AppLovin shares were trading in the mid-$670s and down modestly on the day. The stock’s intraday range has been roughly the mid-$660s to the high-$680s, underscoring the name’s ongoing volatility even during quieter sessions. Investing.com APP stock price action on Dec. 17, 2025 As of mid-session Wednesday, APP was hovering around $675–$676 per share, down fractionally on the day. MarketBeat Despite
17 December 2025
Strategy Inc (MSTR) Stock News Today: Bitcoin Crash Fallout, Analyst Forecasts, and What Investors Are Watching on Dec. 17, 2025

Strategy Inc (MSTR) Stock News Today: Bitcoin Crash Fallout, Analyst Forecasts, and What Investors Are Watching on Dec. 17, 2025

December 17, 2025 — Strategy Inc (NASDAQ: MSTR), the company formerly known as MicroStrategy, is back at the center of the “Bitcoin proxy” trade as investors digest a sharp pullback in crypto markets and a series of capital-structure updates that directly affect the stock’s risk/reward profile. Investing.com+1 While Strategy still runs an enterprise analytics software business, the stock’s day-to-day direction continues to be dominated by (1) Bitcoin’s trend, (2) the premium (or discount) investors assign to Strategy’s Bitcoin holdings, and (3) whether the company can keep funding its strategy without stressing liquidity. Reuters+1 Below is a detailed, publication-ready roundup of
17 December 2025
Zoetis Stock (ZTS) News Today: $1.75B Convertible Notes, Accelerated Buybacks, Dividend Raise, and Analyst Forecasts (Dec. 17, 2025)

Zoetis Stock (ZTS) News Today: $1.75B Convertible Notes, Accelerated Buybacks, Dividend Raise, and Analyst Forecasts (Dec. 17, 2025)

Zoetis Inc. (NYSE: ZTS) stock is back in focus on Wednesday, December 17, 2025, as investors weigh a fresh analyst update against a flurry of recent corporate actions—most notably a $1.75 billion convertible notes financing designed to fund substantial share repurchases, plus a dividend increase heading into 2026. MarketScreener+2investor.zoetis.com+2 Zoetis is the world’s largest pure-play animal health company, with a portfolio spanning companion animal and livestock medicines, vaccines, diagnostics, and technology. Business Wire+1 What’s moving Zoetis stock on Dec. 17, 2025? Two themes are dominating today’s conversation around ZTS stock: From a tape-reading standpoint, Zoetis stock has been trading around
17 December 2025
Braze (BRZE) Stock News Today (Dec. 17, 2025): BTIG Buy Rating, Institutional Buying, and Fresh Forecasts After an AI-Fueled Quarter

Braze (BRZE) Stock News Today (Dec. 17, 2025): BTIG Buy Rating, Institutional Buying, and Fresh Forecasts After an AI-Fueled Quarter

Braze, Inc. (Nasdaq: BRZE) is back in the spotlight on Wednesday, December 17, 2025, as a mix of new analyst coverage, institutional positioning, and post-earnings follow-through keeps the customer engagement software name on traders’ and long-term investors’ watchlists. As of 17:44 UTC, BRZE traded at $35.84, up $1.90 (about 5.6%) on the day, with an intraday range of $34.00–$35.99 and volume around 1.08 million shares. The move comes amid two notable “today” items circulating across market outlets: Below is a detailed breakdown of the day’s news flow, the most relevant financial takeaways from Braze’s latest quarter, and what current forecasts
17 December 2025
OneStream (OS) Stock Jumps as BTIG Initiates Coverage: Latest News, Analyst Targets, and 2026 Outlook (Dec. 17, 2025)

OneStream (OS) Stock Jumps as BTIG Initiates Coverage: Latest News, Analyst Targets, and 2026 Outlook (Dec. 17, 2025)

OneStream, Inc. (NASDAQ: OS) stock is in focus on Wednesday, December 17, 2025, after a notable move higher that coincides with fresh analyst coverage and renewed attention on the company’s longer-term growth narrative in enterprise finance software. Shares of OneStream (OS) rose about 6% in Wednesday trading, changing hands around $18.7 after opening near $17.9 and trading as high as $18.8. Volume was moderate relative to the name’s typical activity. MarketBeat The move comes as Wall Street continues to weigh a mix of catalysts: new buy-side coverage, price-target revisions, the company’s Q3 beat and full-year guidance, ongoing interest in its
Xometry XMTR Stock Rallies on December 17 2025 as Earnings Momentum and Analyst Forecasts Stay in Focus

Xometry XMTR Stock Rallies on December 17 2025 as Earnings Momentum and Analyst Forecasts Stay in Focus

Xometry, Inc. shares (NASDAQ: XMTR) were among the notable U.S. gainers on Wednesday, December 17, 2025, extending a strong run that has increasingly put the AI-powered manufacturing marketplace back on traders’ radar. As of the latest available quote, XMTR traded around $64.66, up about 6% on the day versus the prior close of $60.91. That upside stood out against a softer broader tape at the time, with major U.S. benchmarks showing declines while XMTR appeared on “top gainers” lists—an early signal that the day’s move was being driven more by company-specific positioning and continued “earnings digestion” than by index-level tailwinds.
Alpha Metallurgical Resources (AMR) Stock Surges on Dec. 17, 2025: What’s Driving the Move, Insider Signals, and Analyst Forecasts

Alpha Metallurgical Resources (AMR) Stock Surges on Dec. 17, 2025: What’s Driving the Move, Insider Signals, and Analyst Forecasts

Alpha Metallurgical Resources, Inc. (NYSE: AMR) — one of the most closely watched U.S. metallurgical (coking) coal producers — is back in the spotlight on December 17, 2025, after a sharp move higher that has traders revisiting the company’s newly issued 2026 guidance and a fresh wave of insider-trading headlines. In Wednesday trading, AMR shares were up solidly, trading around the mid-$190s after opening near $190 and printing an intraday range that pushed toward the high-$190s. MarketBeat What follows is a full, publication-ready roundup of today’s news, forecasts, and analyses (17.12.2025) — including the key numbers from Alpha’s 2026 outlook,
17 December 2025

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Go toTop